Instil Bio (Nasdaq: TIL), a clinical-stage biopharmaceutical company developing novel therapies, announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Bronson Crouch will deliver a presentation on Thursday, June 5, 2025, at 4:20 PM ET. Interested parties can access a live webcast of the presentation through the provided weblink. This conference participation represents an opportunity for Instil Bio to showcase its pipeline and developments to the investment community.
Instil Bio (Nasdaq: TIL), una societ脿 biofarmaceutica in fase clinica che sviluppa terapie innovative, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference. Il CEO Bronson Crouch terr脿 una presentazione gioved矛 5 giugno 2025 alle 16:20 ET. Gli interessati potranno seguire la presentazione in diretta streaming tramite il link fornito. Questa partecipazione rappresenta un'opportunit脿 per Instil Bio di mostrare il proprio portafoglio e i progressi raggiunti alla comunit脿 degli investitori.
Instil Bio (Nasdaq: TIL), una compa帽铆a biofarmac茅utica en etapa cl铆nica que desarrolla terapias novedosas, anunci贸 su participaci贸n en la pr贸xima Conferencia Global de Salud de Jefferies. El CEO Bronson Crouch realizar谩 una presentaci贸n el jueves 5 de junio de 2025 a las 4:20 PM ET. Las personas interesadas podr谩n acceder a la transmisi贸n en vivo a trav茅s del enlace proporcionado. Esta participaci贸n representa una oportunidad para que Instil Bio muestre su cartera y avances a la comunidad inversora.
Instil Bio (Nasdaq : TIL), une soci茅t茅 biopharmaceutique en phase clinique d茅veloppant des th茅rapies innovantes, a annonc茅 sa participation 脿 la prochaine conf茅rence mondiale Jefferies Global Healthcare Conference. Le PDG Bronson Crouch pr茅sentera le jeudi 5 juin 2025 脿 16h20 (heure de l'Est). Les personnes int茅ress茅es pourront suivre la pr茅sentation en direct via le lien web fourni. Cette participation repr茅sente une opportunit茅 pour Instil Bio de pr茅senter son portefeuille de projets et ses avanc茅es 脿 la communaut茅 des investisseurs.
Instil Bio (Nasdaq: TIL), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das neuartige Therapien entwickelt, gab seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference bekannt. CEO Bronson Crouch wird am Donnerstag, den 5. Juni 2025, um 16:20 Uhr ET eine Pr盲sentation halten. Interessierte k枚nnen die Pr盲sentation live 眉ber den bereitgestellten Weblink verfolgen. Die Teilnahme an der Konferenz bietet Instil Bio die Gelegenheit, seine Pipeline und Entwicklungen der Investmentgemeinschaft vorzustellen.
Positive
None.
Negative
None.
DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference at 4:20PM ET on Thursday, June 5, 2025. A live webcast will be available using this weblink: .
About Instil Bio Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil's lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumors. For more information, visit聽.
Forward-Looking Statements This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements speak only as the date hereof, and Instil disclaims any obligation to update these statements except as may be required by law.
Contacts: Investor Relations: 1-972-499-3350
FAQ
When is Instil Bio (TIL) presenting at the Jefferies Healthcare Conference 2025?
Instil Bio will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 4:20 PM ET.
Who will represent Instil Bio (TIL) at the Jefferies Healthcare Conference 2025?
Bronson Crouch, Chief Executive Officer of Instil Bio, will present at the conference.
How can I watch Instil Bio's (TIL) presentation at the Jefferies Conference?
A live webcast of the presentation will be available through the weblink: https://wsw.com/webcast/jeff319/til/1708376
What type of company is Instil Bio (TIL)?
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.
